Literature DB >> 28520970

Perspectives on Human Immunodeficiency Virus (HIV) Cure: HIV Persistence in Tissue.

Eli A Boritz1, Daniel C Douek1.   

Abstract

The uneven anatomic distribution of cell subsets that harbor human immunodeficiency virus (HIV) during antiretroviral therapy (ART) complicates investigation of the barriers to HIV cure. Here we propose that while previous studies done largely in blood cells have led to important investigations into HIV latency, other important mechanisms of HIV persistence during ART may not be readily apparent in the bloodstream. We specifically consider as an example the question of ongoing HIV replication during ART. We discuss how growing understanding of key anatomic sanctuaries for the virus can inform future experiments aimed at further clarifying this issue. Published by Oxford University Press for the Infectious Diseases Society of America 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  HIV; T follicular helper cells; antiretroviral therapy.; lymph nodes; phylogenetics

Mesh:

Substances:

Year:  2017        PMID: 28520970      PMCID: PMC5853386          DOI: 10.1093/infdis/jix005

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  65 in total

1.  Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus.

Authors:  Karen A O'Connell; Timothy P Brennan; Justin R Bailey; Stuart C Ray; Robert F Siliciano; Joel N Blankson
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

2.  A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1-infected adults on antiretroviral therapy.

Authors:  Adam M Spivak; Adriana Andrade; Evelyn Eisele; Rebecca Hoh; Peter Bacchetti; Namandjé N Bumpus; Fatemeh Emad; Robert Buckheit; Elinore F McCance-Katz; Jun Lai; Margene Kennedy; Geetanjali Chander; Robert F Siliciano; Janet D Siliciano; Steven G Deeks
Journal:  Clin Infect Dis       Date:  2013-12-12       Impact factor: 9.079

3.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Authors:  T W Chun; L Stuyver; S B Mizell; L A Ehler; J A Mican; M Baseler; A L Lloyd; M A Nowak; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

4.  Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial.

Authors:  Thomas A Rasmussen; Martin Tolstrup; Christel R Brinkmann; Rikke Olesen; Christian Erikstrup; Ajantha Solomon; Anni Winckelmann; Sarah Palmer; Charles Dinarello; Maria Buzon; Mathias Lichterfeld; Sharon R Lewin; Lars Østergaard; Ole S Søgaard
Journal:  Lancet HIV       Date:  2014-09-15       Impact factor: 12.767

5.  Specific tropism of HIV-1 for microglial cells in primary human brain cultures.

Authors:  B A Watkins; H H Dorn; W B Kelly; R C Armstrong; B J Potts; F Michaels; C V Kufta; M Dubois-Dalcq
Journal:  Science       Date:  1990-08-03       Impact factor: 47.728

6.  HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.

Authors:  Maria J Buzón; Marta Massanella; Josep M Llibre; Anna Esteve; Viktor Dahl; Maria C Puertas; Josep M Gatell; Pere Domingo; Roger Paredes; Mark Sharkey; Sarah Palmer; Mario Stevenson; Bonaventura Clotet; Julià Blanco; Javier Martinez-Picado
Journal:  Nat Med       Date:  2010-03-14       Impact factor: 53.440

7.  Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure.

Authors:  J K Wong; H F Günthard; D V Havlir; Z Q Zhang; A T Haase; C C Ignacio; S Kwok; E Emini; D D Richman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

8.  Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta.

Authors:  C Tornatore; A Nath; K Amemiya; E O Major
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

9.  Noninvasive in vivo imaging of CD4 cells in simian-human immunodeficiency virus (SHIV)-infected nonhuman primates.

Authors:  Michele Di Mascio; Chang H Paik; Jorge A Carrasquillo; Jin-Soo Maeng; Beom-Su Jang; In Soo Shin; Sharat Srinivasula; Russ Byrum; Achilles Neria; William Kopp; Marta Catalfamo; Yoshiaki Nishimura; Keith Reimann; Malcolm Martin; H Clifford Lane
Journal:  Blood       Date:  2009-05-05       Impact factor: 22.113

10.  Deep molecular characterization of HIV-1 dynamics under suppressive HAART.

Authors:  Maria J Buzón; Francisco M Codoñer; Simon D W Frost; Christian Pou; Maria C Puertas; Marta Massanella; Judith Dalmau; Josep M Llibre; Mario Stevenson; Julià Blanco; Bonaventura Clotet; Roger Paredes; Javier Martinez-Picado
Journal:  PLoS Pathog       Date:  2011-10-27       Impact factor: 6.823

View more
  10 in total

1.  Establishment of a Novel Humanized Mouse Model To Investigate In Vivo Activation and Depletion of Patient-Derived HIV Latent Reservoirs.

Authors:  Nina C Flerin; Ariola Bardhi; Jian Hua Zheng; Maria Korom; Joy Folkvord; Colin Kovacs; Erika Benko; Ronald Truong; Talia Mota; Elizabeth Connick; R Brad Jones; Rebecca M Lynch; Harris Goldstein
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

2.  HIV-1 in lymph nodes is maintained by cellular proliferation during antiretroviral therapy.

Authors:  William R McManus; Michael J Bale; Jonathan Spindler; Ann Wiegand; Andrew Musick; Sean C Patro; Michele D Sobolewski; Victoria K Musick; Elizabeth M Anderson; Joshua C Cyktor; Elias K Halvas; Wei Shao; Daria Wells; Xiaolin Wu; Brandon F Keele; Jeffrey M Milush; Rebecca Hoh; John W Mellors; Stephen H Hughes; Steven G Deeks; John M Coffin; Mary F Kearney
Journal:  J Clin Invest       Date:  2019-07-30       Impact factor: 14.808

Review 3.  Eradication of HIV from Tissue Reservoirs: Challenges for the Cure.

Authors:  Rebecca Rose; David J Nolan; Ekaterina Maidji; Cheryl A Stoddart; Elyse J Singer; Susanna L Lamers; Michael S McGrath
Journal:  AIDS Res Hum Retroviruses       Date:  2017-08-07       Impact factor: 2.205

4.  Evaluation of the Innate Immune Modulator Acitretin as a Strategy To Clear the HIV Reservoir.

Authors:  Edurne Garcia-Vidal; Marc Castellví; Maria Pujantell; Roger Badia; Antoni Jou; Lucia Gomez; Teresa Puig; Bonaventura Clotet; Ester Ballana; Eva Riveira-Muñoz; José A Esté
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

5.  Subclinical Genital Herpes Shedding in HIV/Herpes Simplex Virus 2-Coinfected Women during Antiretroviral Therapy Is Associated with an Increase in HIV Tissue Reservoirs and Potentially Promotes HIV Evolution.

Authors:  Tajanna Stinn; Steve Kuntz; Dana Varon; Meei-Li Huang; Stacy Selke; Samuel Njikan; Emily S Ford; Joan Dragavon; Robert W Coombs; Christine Johnston; Marta E Bull
Journal:  J Virol       Date:  2020-12-09       Impact factor: 5.103

6.  Proliferation of HIV-infected renal epithelial cells following virus acquisition from infected macrophages.

Authors:  Kelly Hughes; Guray Akturk; Sacha Gnjatic; Benjamin Chen; Mary Klotman; Maria Blasi
Journal:  AIDS       Date:  2020-09-01       Impact factor: 4.632

Review 7.  Toward T Cell-Mediated Control or Elimination of HIV Reservoirs: Lessons From Cancer Immunology.

Authors:  Geetha Mylvaganam; Adrienne G Yanez; Marcela Maus; Bruce D Walker
Journal:  Front Immunol       Date:  2019-09-10       Impact factor: 7.561

8.  The evaluation of risk-benefit ratio for gut tissue sampling in HIV cure research.

Authors:  Vikram Mehraj; Peter Ghali; Rayoun Ramendra; Cecilia Costiniuk; Bertrand Lebouché; Rosalie Ponte; Robert Reinhard; Jose Sousa; Nicolas Chomont; Eric A Cohen; Petronela Ancuta; Jean-Pierre Routy
Journal:  J Virus Erad       Date:  2017-10-01

Review 9.  Virus-Specific T Cell Therapies for HIV: Lessons Learned From Hematopoietic Stem Cell Transplantation.

Authors:  Ping-Hsien Lee; Michael D Keller; Patrick J Hanley; Catherine M Bollard
Journal:  Front Cell Infect Microbiol       Date:  2020-07-07       Impact factor: 5.293

10.  The tetraspanin CD151 marks a unique population of activated human T cells.

Authors:  Mildred D Perez; Lillian Seu; Kelsey E Lowman; David C Moylan; Christopher Tidwell; Shekwonya Samuel; Alexandra Duverger; Frederic H Wagner; Eric Carlin; Vishal Sharma; Brandon Pope; Chander Raman; Nathan Erdmann; Jayme Locke; Hui Hu; Steffanie Sabbaj; Olaf Kutsch
Journal:  Sci Rep       Date:  2020-09-25       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.